[Definition of high-priced and very high-priced drugs for Argentina].
This work collect the experience and vision of representatives of important institutions in our country and provides a key definition for addressing these technologies.
Authors
- Fernando Tortosa (ORCID: https://orcid.org/0000-0002-0303-6055)
- María Julia Meschini
- Gustavo H. Marín (ORCID: https://orcid.org/0000-0002-6380-6453)
- Manuel Donato (ORCID: https://orcid.org/0000-0002-5949-3845)
- Daniel Esteban Manoukian
- A. Iglesias (ORCID: https://orcid.org/0000-0002-4016-5980)
- Guadalupe Montero (ORCID: https://orcid.org/0000-0003-0933-6195)
Institutions
- National University of General San Martín (AR)
- Universidad Nacional del Centro de la Provincia de Buenos Aires (AR)
- National University of Río Negro (AR)
- Ministerio de Salud (AR)
- Hospital de Clínicas "José de San Martín" (AR)
- Agencia de Evaluación de Tecnologías Sanitarias (ES)
- Universidad Nacional del Comahue (AR)
Publication Details
- Journal
- PubMed
- Published
- 2025-01-01
- Primary Topic
- Pharmaceutical Economics and Policy
- Type
- article